OMERS ADMINISTRATION Corp Has $2.77 Million Position in Agilent Technologies, Inc. (NYSE:A)

OMERS ADMINISTRATION Corp lowered its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 14.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,634 shares of the medical research company's stock after selling 3,350 shares during the quarter. OMERS ADMINISTRATION Corp's holdings in Agilent Technologies were worth $2,772,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. CKW Financial Group lifted its holdings in Agilent Technologies by 114.9% during the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company's stock valued at $25,000 after purchasing an additional 100 shares during the last quarter. Global X Japan Co. Ltd. lifted its position in Agilent Technologies by 161.1% during the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after acquiring an additional 116 shares during the last quarter. Redwood Park Advisors LLC bought a new stake in shares of Agilent Technologies during the fourth quarter worth approximately $27,000. Lee Danner & Bass Inc. acquired a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $29,000. Finally, Hanson & Doremus Investment Management lifted its holdings in Agilent Technologies by 66.5% during the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after purchasing an additional 105 shares during the last quarter.

Insider Buying and Selling

In other news, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares in the company, valued at $4,161,931.02. This represents a 4.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the transaction, the vice president now owns 21,786 shares in the company, valued at approximately $2,657,456.28. The trade was a 8.05% decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Price Performance

Shares of NYSE A traded up $1.36 during midday trading on Friday, reaching $113.76. 1,811,948 shares of the company were exchanged, compared to its average volume of 1,904,117. The stock's 50-day moving average price is $110.44 and its 200-day moving average price is $128.17. The stock has a market cap of $32.43 billion, a P/E ratio of 26.15, a PEG ratio of 3.21 and a beta of 1.27. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $154.95.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.54 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st were issued a $0.248 dividend. The ex-dividend date was Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.87%. Agilent Technologies's dividend payout ratio (DPR) is presently 22.76%.

Wall Street Analyst Weigh In

A has been the topic of several research reports. Jefferies Financial Group decreased their price target on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research note on Monday, April 21st. Wells Fargo & Company reduced their price target on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. Barclays dropped their price objective on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. TD Cowen increased their target price on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a report on Thursday, April 10th. Finally, Robert W. Baird dropped their price target on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research note on Thursday, February 27th. Seven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, Agilent Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $143.00.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.